MIT researchers introduce CuRVE, a protein-labeling technique enabling uniform staining across entire tissues.

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals ...

In this manuscript the authors established a novel three-dimensional culture system for stratified epithelia that allows epithelial cells to undergo epithelial-to-mesenchymal transition (EMT) and ...

BENGALURU: When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious intruder? How many more epidemics or pandemics can the human civilisation sustain — Covid ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

GBS begins with tingling or numbness in the feet and hands, followed by muscle weakness and difficulty moving joints.